Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt

Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt

Background: Sleep disturbance (SD) is a common occurrence in individuals with cirrhosis and significantly impacts their quality of life. Datas regarding post transjugular intrahepatic portosystemic shunt (TIPS) SD are scarce. This study aimed to explore the incidence and outcomes of post-TIPS SD. Me...

Full description

Bibliographic Details
Main Authors:	Zhao, M, Yan, Y, Wang, X, Liu, B, Luo, X
Format:	Journal article
Language:	English
Published:	BioMed Central 2024

Similar Items

Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt
by: Ming Zhao, et al.
Published: (2024-10-01)

Transjugular intrahepatic portosystemic shunt with gastric vein embolization in liver cirrhosis
by: V. I. Korobka, et al.
Published: (2024-09-01)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
by: Chaoyang Wang, et al.
Published: (2022-11-01)

Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis
by: Chih-Horng Wu, et al.
Published: (2023-08-01)

Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
by: Lena Stockhoff, et al.
Published: (2020-01-01)

Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Refractory Transudative Chylothorax due to Liver Cirrhosis
by: Muhammad Farhan Khaliq, et al.
Published: (2020-01-01)

RECURRENT STOMAL VARICEAL BLEEDING IN CIRRHOSIS: MANAGEMENT WITH TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AND EMBOLIZATION
by: Leandro Armani Scaffaro, et al.
Published: (2023-05-01)

Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis
by: Claus Christian Pieper, et al.
Published: (2021-03-01)

High Interleukin-8 Levels Associated With Decreased Survival in Patients With Cirrhosis Following Transjugular Intrahepatic Portosystemic Shunt
by: Guofeng Liu, et al.
Published: (2022-02-01)

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
by: Zhang Cheng, et al.
Published: (2019-12-01)

Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes
by: Donna Niedzwiecki, et al.
Published: (2022-01-01)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
by: Long Huang, et al.
Published: (2015-01-01)

Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt
by: Christine March, et al.
Published: (2023-10-01)

Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt
by: Maria Chiara Meucci, et al.
Published: (2022-11-01)

Transjugular intrahepatic portosystemic shunt for chylous ascites in a patient with recurrent cirrhosis following liver transplantation
by: Jason T. Salsamendi, MD, et al.
Published: (2017-03-01)

Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites
by: Ahmad Parvinian,, et al.
Published: (2014-01-01)

The transjugular intrahepatic portosystemic shunt (TIPSS) procedure - a review
by: Ian C. Duncan
Published: (2004-06-01)

The Pull-Through Technique for Recanalization of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
by: Si-liang Chen, et al.
Published: (2020-01-01)

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt
by: Yang Chen, et al.
Published: (2023-01-01)

A systematic review of preoperative transjugular intrahepatic portosystemic shunt prior to extrahepatic, abdominal surgery in patients with cirrhosis
by: Mahnur Haider, et al.
Published: (2024-09-01)

Changes in characteristics of gut microbiota and their correlation with clinical indicators in cirrhosis patients after transjugular intrahepatic portosystemic shunt
by: LI Shengpeng, et al.
Published: (2024-06-01)

Evolution, progress, and prospects of research on transjugular intrahepatic portosystemic shunt applications
by: Peng Wang, et al.
Published: (2021-05-01)

Combined Y-configured stents for revising occluded transjugular intrahepatic portosystemic shunt
by: Xiaoze Wang, et al.
Published: (2021-03-01)

Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy
by: Brandon Toliver, et al.
Published: (2024-08-01)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
by: Gilles Pomier-Layrargues, et al.
Published: (2012-01-01)

Permanent hilar biliary obstruction after transjugular intrahepatic portosystemic shunt
by: Jie Zhang, et al.
Published: (2023-04-01)

Transjugular intrahepatic portosystemic shunt trends in China: A brief review
by: Xiao JiangQiang, et al.
Published: (2018-04-01)

The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer.
by: Katherine Wong, et al.
Published: (2018-01-01)

Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study
by: Hong-Liang Wang, et al.
Published: (2021-10-01)

Transjugular intrahepatic portosystemic shunt for portal hypertension in a patient with Caroli disease
by: Baoli Qi, et al.
Published: (2023-07-01)

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
by: Hae Lim Lee, et al.
Published: (2022-04-01)

Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt
by: Qian Zhang, et al.
Published: (2025-01-01)

Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension
by: Laura Büttner, et al.
Published: (2024-08-01)

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
by: Xuefeng Luo, et al.
Published: (2014-01-01)

Outcome of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis and Refractory Hepatic Hydrothorax: A Systematic Review and Meta-analysis
by: Suprabhat Giri, et al.
Published: (2024-10-01)

Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis
by: Ding-Fan Guo, et al.
Published: (2022-08-01)

Systemic and Splanchnic Lipopolysaccharide and Endothelin-1 Plasma Levels in Liver Cirrhosis before and after Transjugular Intrahepatic Portosystemic Shunt
by: Jiaxiang Meng, et al.
Published: (2016-01-01)

Safety and efficacy of transjugular intrahepatic portosystemic shunt therapy for symptomatic portal biliopathy
by: Feng Zhang, et al.
Published: (2023-09-01)

Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment
by: Dengke Teng, et al.
Published: (2018-10-01)

Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt
by: Lee, W.S., et al.
Published: (2001)